Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations

18Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Patients with primary immunodeficiency (PIDs) depend on the presence of a variety of antibody specificities in intravenous immunoglobulin (IVIG). Using the tick-borne encephalitis virus (TBEV), geographic variability in IVIG antibody content was shown. Care should therefore be exercised when treating PIDs in a given geography, as only locally sourced plasma contains the antibody specificities against the circulating pathogens in the given locality. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Rabel, P. O., Planitzer, C. B., Farcet, M. R., & Kreil, T. R. (2012). Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations. Clinical and Vaccine Immunology, 19(4), 623–625. https://doi.org/10.1128/CVI.05705-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free